YKL-40 Is Elevated in Patients with Chronic Obstructive Pulmonary Disease and Activates Alveolar Macrophages
- 1 October 2008
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 181 (7), 5167-5173
- https://doi.org/10.4049/jimmunol.181.7.5167
Abstract
YKL-40 is a chitin-binding protein that is elevated in patients with various inflammatory conditions associated with ongoing remodeling. We investigated whether the levels of YKL-40 were up-regulated in the circulation and the airways of patients with chronic obstructive pulmonary disease (COPD), and whether it promoted the production of inflammatory mediators from macrophages. Serum, bronchoalveolar lavage (BAL), bronchial biopsies, lung tissue specimens, and alveolar macrophages from never-smokers (n = 15), smokers without COPD (n = 20), and smokers with COPD (n = 30) were assessed for YKL-40 levels and immunolocalization. In addition, YKL-40-induced mediator release from alveolar macrophages was examined. We found that smokers with COPD had elevated levels of YKL-40 in serum (p ≤ 0.027) and BAL (p ≤ 0.007), more YKL-40-positive cells in bronchial biopsies (p ≤ 0.03), and a greater proportion of alveolar macrophages expressing YKL-40 than smokers without COPD or never-smokers. YKL-40 levels in serum and BAL were associated with airflow obstruction (pre-β2 agonist forced expiratory volume in 1 s, rs = −0.3892, p = 0.0072 and rs = −0.5491, p < 0.0001, respectively) and impaired diffusion lung capacity (transfer factor of the lung for carbon monoxide, rs = −0.4667, p = 0.002 and rs = −0.3854, p = 0.0045, respectively). TNF-α stimulated YKL-40 synthesis in alveolar macrophages from smokers with COPD, and exposure of these cells to YKL-40 promoted the release of IL-8, MCP-1, MIP-1α, and metalloproteinase-9. We conclude that YKL-40 is up-regulated in COPD, in which it may contribute to tissue inflammation and remodeling by sustaining the synthesis of proinflammatory and fibrogenic chemokines and of metalloproteinases by alveolar macrophages.Keywords
This publication has 29 references indexed in Scilit:
- A Chitinase-like Protein in the Lung and Circulation of Patients with Severe AsthmaNew England Journal of Medicine, 2007
- Serum YKL-40 levels in patients with coronary artery diseaseCoronary Artery Disease, 2007
- HC-gp39 contributes to chondrocyte differentiation by inducing SOX9 and type II collagen expressionsOsteoarthritis and Cartilage, 2007
- The Mammalian Chitinase-like Lectin, YKL-40, Binds Specifically to Type I Collagen and Modulates the Rate of Type I Collagen Fibril FormationPublished by Elsevier BV ,2006
- Mediators of Chronic Obstructive Pulmonary DiseasePharmacological Reviews, 2004
- Alveolar Macrophages as Orchestrators of COPDCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2004
- The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathwaysBiochemical Journal, 2002
- Strong Induction of Members of the Chitinase Family of Proteins in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Chitotriosidase, a chitinase, and the 39‐kDa human cartilage glycoprotein, a chitin‐binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophagesEuropean Journal of Biochemistry, 1998
- Molecular Characterization of the Gene for Human Cartilage gp-39 (CHI3L1), a Member of the Chitinase Protein Family and Marker for Late Stages of Macrophage DifferentiationGenomics, 1997